港股異動 | 海吉亞醫療(6078.HK)漲約8% 去年淨利潤大增155.9%
格隆匯3月30日丨海吉亞醫療(6078.HK)現漲7.87%,報32.9港元,盤中曾一度大漲逾14%,總市值超200億港元。公司午間公吿,2021年收入增加65.2%至23.15億元人民幣(下同),毛利增加57.8%至7.6億元,淨利潤更是大增155.9%至4.53億元。集團自有醫院品牌影響力逐步增強,患者黏性持續提升,就診人次不斷增加。此外,集團積極拓展診療項目,豐富治療手段,提升管理效率,醫院單牀產出不斷提升。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.